Zhenyu Zhang

Jiangsu University — China

Medicine · Health Sciences

19h-index1.8kcitations104works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Helicobacter pylori-related gastroenterology studies(51), Gastric Cancer Management and Outcomes(17), Gastroesophageal reflux and treatments(16), Eosinophilic Esophagitis(12), Veterinary medicine and infectious diseases(11)

Publications104 total

Feature of the Oral Bacteria in Patients with Neuroendocrine Tumors of Pancreas
2025Open Access
Multiple arachnoid membrane opening to promote angiogenesis in adult patients with moyamoya disease after combined bypass surgery: a multicenter randomized controlled clinical trial
Journal of neurosurgery·2025
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
˜The œLancet. Gastroenterology & hepatology·2025· 1 cited
Ten‐Day Versus 14‐Day Vonoprazan and Amoxicillin Dual Therapy for the Firstline Eradication of <scp> <i>Helicobacter pylori</i> </scp> Infection: A Multicenter, Randomized Controlled Trial
Helicobacter·2025· 2 cited
LONG-TIME BEHAVIOR OF AVIAN INFLUENZA MODEL WITH NONLOCAL DIFFUSION
Journal of Applied Analysis & Computation·2025Open Access
Intelligent Lighting Control System for Street and Landscape Lights Based on ZigBee and GPRS
European Journal of Theoretical and Applied Sciences·2025Open Access
Efficacy of Three Amoxicillin Doses in Vonoprazan Dual Therapy for <scp><i>Helicobacter pylori</i></scp> Eradication: A Randomized Noninferiority Trial
Helicobacter·2025Open Access
Clinical evaluation of personalized Helicobacter pylori treatment guided by PCR detection from fecal samples: a real-world study
Frontiers in Cellular and Infection Microbiology·2025· 1 citedOpen Access
Comparison of Cefuroxime‐Based Dual Therapy With Quadruple Therapy in <i>Helicobacter pylori</i>‐Infected Treatment‐Naive Patients: A Prospective, Multicenter, Randomized Controlled Trial
Helicobacter·2025· 1 citedOpen Access
Vonoprazan-based quadruple therapy is non-inferior to esomeprazole-based quadruple therapy for Helicobacter pylori eradication: A multicenter, double-blind, randomized, phase 3 study
Chinese Medical Journal·2025· 3 citedOpen Access
Quantitative Study on Provenance Contribution of the Yarlung Zangbo River Based on Rare Earth Elements Signatures
SSRN Electronic Journal·2025Open Access
Helicobacter Pylori Prevalence and Antibiotic Resistance in Jiangsu Province, China Using the Fecal Test Coupled with MALDI-TOF Mass Spectrometry
SSRN Electronic Journal·2025Open Access
Helicobacter Pylori&amp;nbsp; Prevalence&amp;nbsp;And Antibiotic Resistance in Jiangsu Province, China Using the Fecal Test&amp;nbsp;Coupled with MALDI-TOF&amp;nbsp;Mass Spectrometry
SSRN Electronic Journal·2025Open Access
A new perspective on bone development in vitamin D deficiency-associated obese children
Scientific Reports·2024· 5 citedOpen Access
Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial
The Lancet Microbe·2024· 23 citedOpen Access
Laparotomy versus laparoscopy for the treatment of adnexal torsion during pregnancy
BMC Pregnancy and Childbirth·2024· 2 citedOpen Access
Efficacy and safety of tegoprazan (LXI-15028) vs. esomeprazole in patients with erosive esophagitis: A multicenter, randomized, double-blind, non-inferiority phase Ⅲ trial
Chinese Medical Journal·2024· 7 citedOpen Access
IDDF2024-ABS-0375 Multi-centre, open-label, randomized controlled trial of amoxicillin dosage in vonoprazan dual helicobacter pylori therapy: effects on cure rate, gut microbiota and antibiotic resistome
2024
Simultaneous application of oral and intravaginal probiotics for Helicobacter pylori and its antibiotic-therapy-induced vaginal dysbacteriosis
npj Biofilms and Microbiomes·2024· 11 citedOpen Access
Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection
Scientific Reports·2024· 8 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Zongdan Jiang(13), Yong Xie(11), Shukui Wang(8), Ye Chen(6), Nonghua Lü(6), Zhibing Wang(5), Bangshun He(5), Yiqi Du(5), Hong Cheng(5), Xu Shu(5), Guoxin Zhang(5), Hailu Wu(5), Kewei Hu(4), Hong Lü(4), Jiangbin Wang(4), Xuehong Wang(4), Pengyuan Zheng(4), Yin Zhu(4), Lijuan Huo(4), Zhaotao Duan(4)